XML 27 R19.htm IDEA: XBRL DOCUMENT v3.24.2
Earnings Per Share
6 Months Ended
Jun. 30, 2024
Earnings Per Share [Abstract]  
Earnings Per Share

11. EARNINGS PER SHARE

The following table sets forth the components of the denominator for the computation of basic and diluted earnings per share for net loss attributable to Community Health Systems, Inc. stockholders:

 

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

June 30,

 

 

June 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Weighted-average number of shares outstanding — basic

 

 

132,344,504

 

 

 

130,659,672

 

 

 

131,808,274

 

 

 

130,176,976

 

Effect of dilutive securities:

 

 

 

 

 

 

 

 

 

 

 

 

Restricted stock awards

 

 

 

 

 

 

 

 

 

 

 

 

Employee stock options

 

 

 

 

 

 

 

 

 

 

 

 

Other equity-based awards

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-average number of shares outstanding — diluted

 

 

132,344,504

 

 

 

130,659,672

 

 

 

131,808,274

 

 

 

130,176,976

 

 

The Company generated a loss attributable to Community Health Systems, Inc. stockholders for each of the three- and six-month periods ended June 30, 2024 and 2023, so the effect of dilutive securities is not considered because their effect would be antidilutive. If the Company had generated income during the three months ended June 30, 2024 and 2023, the effect of restricted stock awards, employee stock options, and other equity-based awards on the diluted shares calculation would have been an increase of 864,816 shares and 202,182 shares, respectively. If the Company had generated income during the six months ended June 30, 2024 and 2023, the effect of restricted stock awards, employee stock options, and other equity-based awards on the diluted shares calculation would have been an increase of 654,307 shares and 335,188 shares, respectively.

 

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

June 30,

 

 

June 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Dilutive securities outstanding not included in the computation
   of earnings per share because their effect is antidilutive:

 

 

 

 

 

 

 

 

 

 

 

 

Employee stock options and restricted stock awards

 

 

5,771,995

 

 

 

7,191,908

 

 

 

5,786,164

 

 

 

6,540,493